D Daiichi Sankyo
Japanese pharmaceutical company
Updates & Highlights
marketscreener.com · 5 days ago
Daiichi Sankyo : Consolidated Financial Statements and Independent Auditor's Report for FY2025PDF
marketscreener.com · 6 days ago
Daiichi Sankyo Secures 200 Billion Yen Loan
Fierce Biotech · 6 days ago
‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game
Recent Openings
View all 1 jobs arrow_forwardData Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
All Jobs
Data Scientist - Pharmaceutical Development and Manufacturing (m/f/d)
location_on Pfaffenhofen an der Ilm, BY, DE
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Daiichi Sankyo?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentDaiichi Sankyo : Consolidated Financial Statements and Independent Auditor's Report for FY2025PDF
Daiichi Sankyo : Consolidated Financial Statements and Independent Auditor's Report for FY2025PDF
marketscreener.com · 5 days ago
Daiichi Sankyo Secures 200 Billion Yen Loan
Daiichi Sankyo Secures 200 Billion Yen Loan
marketscreener.com · 6 days ago
‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game
‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game
Fierce Biotech · 6 days ago
Daiichi Sankyo Company, Limited Concludes Money Loan Agreement with Financial Covenants
Daiichi Sankyo Company, Limited Concludes Money Loan Agreement with Financial Covenants
marketscreener.com · 6 days ago
Daiichi Sankyo’s Vanflyta approved in China
Daiichi Sankyo’s Vanflyta approved in China
The Pharma Letter · 7 days ago
Daiichi Sankyo Co Ltd - Notice Regarding Conclusion Of A Money Loan Agreement With Financial Covenants
Daiichi Sankyo Co Ltd - Notice Regarding Conclusion Of A Money Loan Agreement With Financial Covenants
TradingView · 7 days ago
Daiichi Sankyo : Vanflyta® Approved in China as First and Only FLT3 Inhibitor for Patients with Newly Diagnosed FLT3-ITD Positive AML
Daiichi Sankyo : Vanflyta® Approved in China as First and Only FLT3 Inhibitor for Patients with Newly Diagnosed FLT3-ITD Positive AML
marketscreener.com · 9 days ago
Daiichi Sankyo's trademark win falls short on online-monitoring costs
Daiichi Sankyo's trademark win falls short on online-monitoring costs
MLex · 13 days ago
How Daiichi Sankyo aims to become a top five oncology player by 2035
How Daiichi Sankyo aims to become a top five oncology player by 2035
Labiotech.eu · 13 days ago
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
marketscreener.com · 15 days ago
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
simplywall.st · 17 days ago
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
simplywall.st · 17 days ago
Assessing Daiichi Sankyo (TSE:4568) Valuation After Recent Share Price Weakness
Assessing Daiichi Sankyo (TSE:4568) Valuation After Recent Share Price Weakness
simplywall.st · 20 days ago
JPMorgan cuts Daiichi Sankyo stock rating on weak outlook
JPMorgan cuts Daiichi Sankyo stock rating on weak outlook
Investing.com · 21 days ago
Assessing Daiichi Sankyo Company (TSE:4568) Valuation After Recent Share Price Weakness
Assessing Daiichi Sankyo Company (TSE:4568) Valuation After Recent Share Price Weakness
Yahoo Finance · 21 days ago
Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness?
Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness?
simplywall.st · 25 days ago
Daiichi Sankyo concludes pcpa letter of intent for Vanflyta®
Daiichi Sankyo concludes pcpa letter of intent for Vanflyta®
marketscreener.com · 26 days ago
Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta®
Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta®
TradingView · 26 days ago
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
PR Newswire Canada · 26 days ago
Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO
Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO
marketscreener.com · 26 days ago